Torrado Laura A, Fivgas George D
Louisiana State University (LSU) School of Medicine, New Orleans, LA, USA.
The Retina Center, 7777 Hennessy Blvd, Suite 3000. Baton Rouge, LA, 70808, USA.
Am J Ophthalmol Case Rep. 2020 Dec 13;20:100995. doi: 10.1016/j.ajoc.2020.100995. eCollection 2020 Dec.
To report the findings of unilateral cystoid macular edema (CME) associated with bilateral sub-foveal hyperreflectivity in a patient previously diagnosed with breast cancer and treated with docetaxel and cyclophosphamide.
A 69-year-old female on docetaxel and cyclophosphamide chemotherapy treatment for breast cancer developed blurry vision 20 days after initiation of therapy. Ophthalmic examination revealed reduced visual acuity with bilateral retinal pigment epithelium mottling and annular sub-foveal thickening in the left eye. Optical coherence tomography (OCT) showed cystoid macular changes in the right eye and central sub-macular hyperreflectivity of outer layers in both eyes. Six-months after discontinuation of therapy, OCT findings remained unchanged and visual acuity did not improve.
CME may occur in patients taking taxanes, but this finding associated with sub-macular hyperreflectivity of the outer layers in diagnostic testing has never been reported before. Sub-macular deposits found in this patient may be responsible for decreased vision and did not respond to cessation of therapy.
报告一名先前诊断为乳腺癌并接受多西他赛和环磷酰胺治疗的患者出现单侧黄斑囊样水肿(CME)并伴有双侧黄斑下高反射率的情况。
一名69岁女性因乳腺癌接受多西他赛和环磷酰胺化疗,治疗开始20天后出现视力模糊。眼科检查发现视力下降,伴有双侧视网膜色素上皮斑驳和左眼黄斑下环形增厚。光学相干断层扫描(OCT)显示右眼有黄斑囊样改变,双眼黄斑中心外层有高反射率。停药6个月后,OCT检查结果未变,视力也未改善。
服用紫杉烷类药物的患者可能会发生CME,但这种与诊断测试中黄斑外层高反射率相关的发现此前从未有过报道。该患者发现的黄斑下沉积物可能是视力下降的原因,且对停药无反应。